The International Journal of MCH and AIDS (IJMA) is a U.S-based multidisciplinary, peer-reviewed, global health, open access journal that publishes original research articles, review articles, clinical studies, evaluation studies, policy analyses, and commentaries, opinions in all areas of maternal, infant, child health, (MCH) and HIV/AIDS in low and middle-income countries, and in populations that are experiencing health disparities (i.e. inequalities) around the world.
IJMA focuses on the social determinants of health and disease as well as on the disparities in the burden of communicable, non-communicable, and neglected tropical diseases affecting infants, children, women, adults, and families across the life span in developing countries and around the world.
The journal focuses on the intersection between MCH and HIV/AIDS around the world but more especially in the low and middle-income countries (LMICs), as classified by the World Bank. Diseases or healthcare policy issues impacting populations in LMICs, also known as developing countries or the global South, are currently under-documented and underreported in existing western-based, peer-reviewed journals. IJMA therefore places a huge emphasis on the documentation and dissemination of work and new findings especially when those papers are the products of collaboration between researchers in the global North and South.
IJMA’s primary focus is on the broader life-span trajectory of MCH and HIV/AIDS issues in developing countries. The journal’s Editors also recognize that there are widening socioeconomic and health inequalities in populations in developed countries; therefore, IJMA welcomes high-quality papers, opinion articles, and commentaries from scientists, researchers, policy experts, and other professionals working with health disparity populations and issues in the developed countries of the world. This includes cross-national studies that compare health and social inequalities between and within racial or different social and economic groups, as well as within or between developing and developed countries.
Scope and Areas of Coverage
The journal covers, but is not limited to, the following global health subject areas:
- Life expectancy, cause-specific mortality, and human development,
- Maternal, infant, child, and youth mortality and morbidity in developing countries,
- Determinants and consequences of childhood and adolescent obesity and sedentary behaviors,
- Smoking, alcohol, substance-use, violence and injury prevention,
- Quality of life and mental health disparities affecting MCH and HIV/AIDS populations,
- Social, behavioral, and biological determinants of MCH and HIV/AIDS
- Disparities in health and well-being based on gender, race, ethnicity, immigrant status, social class, education, income, disability status, etc.,
- Region and/or country specific studies using different methodologies,
- Family health, including changing dynamics of modern families,
- Human sexuality and human development,
- Neglected tropical diseases,
- Use of science, technology and innovation to address national and global health issues
- Technological innovations to address family health, MCH and HIV/AIDS,
- Cross-national research on MCH and HIV/AIDS issues across the world,
- Issues of resilience among populations impacted by HIV/AIDS,
- Linkages between research results and national public policy,
- Applications of surveillance, trend, and multilevel methods, and use of novel approaches in both quantitative and qualitative research studies.
Effective October 30, 2016, our Article Processing Charges (APC) will increase from $105 for authors in developed countries to $500 and from $65 for authors in developing countries to $300 to cover costs and remain sustainable.
Vol 6, No 1
Table of Contents
How Much are Ecuadorians Willing to Pay to Reduce Maternal Mortality? Results from a Pilot Study on Contingent Valuation
Maria Isabel Roldos, MPA, MA, DrPH, Phaedra Corso, PhD, Justin Ingels, PhD
Do Recommendations by Healthcare Providers, Family-members, Friends, and Individual Self-Efficacy Increase Uptake of Hepatitis B Screening? Results of a Population-Based Study of Asian Americans
Xiaoxiao Lu, MD, MPH, Hee-Soon Juon, PhD, Sunmin Lee, ScD
Evaluation of Cortez Onestep Chlamydia RapicardTM Insta Test for the Detection of Chlamydia Trachomatis in Pregnant Women at Mbare Polyclinic in Harare, Zimbabwe
Stephen Stephen, MSc, Chiwoneso Gwyneth Elizabeth Muchaneta-Kubara, PhD, Marshall Wesley Munjoma, PhD, Gibson Mandozana, PhD